CS
Credit Suisse Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1201
Lazard
LAZ
$5.21B
|
CS
Craig Siegenthaler
| $55.22 | $50 |
9%
downside
| Neutral |
12 Apr ‘21
4 years ago |
|
1202
Bilibili
BILI
$9.96B
|
KF
Kenneth Fong
| $24.12 | $140 |
480%
upside
| Outperform |
8 Apr ‘21
4 years ago |
|
1203
Ubiquiti
UI
$36.2B
|
SB
Sami Badri
| $598.70 | $126 |
79%
downside
| Underperform |
1 Apr ‘21
4 years ago |
|
1204
Travelers Companies
TRV
$61.6B
|
MZ
Michael Zaremski
| $273.55 | $153 |
44%
downside
| Neutral |
1 Apr ‘21
4 years ago |
|
1205
Mersana Therapeutics
MRSN
$38.2M
|
BC
Brad Canino
| $7.66 | $450 |
5,775%
upside
| Neutral |
31 Mar ‘21
4 years ago |
|
1206
Zymeworks
ZYME
$1.15B
|
BC
Brad Canino
| $15.23 | $55 |
261%
upside
| Outperform |
31 Mar ‘21
4 years ago |
|
1207
Exelixis
EXEL
$10.3B
|
BC
Brad Canino
| $38.28 | $30 |
22%
downside
| Outperform |
31 Mar ‘21
4 years ago |
|
1208
T Rowe Price
TROW
$23.5B
|
CS
Craig Siegenthaler
| $107.15 | $181 |
69%
upside
| Neutral |
30 Mar ‘21
4 years ago |
|
1209
Upland Software
UPLD
$70.5M
|
YC
Yaoxian Chew
| $2.45 | $58 |
2,267%
upside
| Outperform |
29 Mar ‘21
4 years ago |
|
1210
Envista
NVST
$3.46B
|
EW
Erin Wright
| $20.81 | $46 |
121%
upside
| Outperform |
25 Mar ‘21
4 years ago |
|
1211
NXP Semiconductors
NXPI
$56.4B
|
JP
John Pitzer
| $223.69 | $250 |
12%
upside
| Outperform |
22 Mar ‘21
4 years ago |
|
1212
Fulcrum Therapeutics
FULC
$392M
|
MA
Martin Auster
| $7.24 | $26 |
259%
upside
| Outperform |
22 Mar ‘21
4 years ago |
|
1213
Hartford Financial Services
HIG
$36.8B
|
MZ
Michael Zaremski
| $130.84 | $82 |
37%
downside
| Outperform |
19 Mar ‘21
4 years ago |
|
1214
Lennar Class A
LEN
$35.6B
|
AB
Adam Baumgarten
| $137.45 | $107 |
22%
downside
| Neutral |
18 Mar ‘21
4 years ago |
|
1215
Starwood Property Trust
STWD
$7.57B
|
DH
Douglas Harter
| $20.61 | $26 |
26%
upside
| Outperform |
17 Mar ‘21
4 years ago |
|
1216
Blackstone Mortgage Trust
BXMT
$3.41B
|
DH
Douglas Harter
| $19.87 | $33 |
66%
upside
| Neutral |
17 Mar ‘21
4 years ago |
|
|
ARI
1217
Apollo Commercial Real Estate
ARI
$1.53B
|
DH
Douglas Harter
| $11.02 | $15 |
36%
upside
| Neutral |
17 Mar ‘21
4 years ago |
|
|
ACRE
1218
Ares Commercial Real Estate
ACRE
$267M
|
DH
Douglas Harter
| $4.86 | $16 |
229%
upside
| Outperform |
17 Mar ‘21
4 years ago |
|
1219
Brighthouse Financial
BHF
$2.79B
|
AK
Andrew Kligerman
| $48.81 | $42 |
14%
downside
| Neutral |
17 Mar ‘21
4 years ago |
|
1220
Medpace
MEDP
$13.6B
|
EW
Erin Wright
| $485.59 | $181 |
63%
downside
| Outperform |
17 Mar ‘21
4 years ago |
|
1221
Solid Biosciences
SLDB
$389M
|
MA
Martin Auster
| $5 | $120 |
2,300%
upside
| Neutral |
16 Mar ‘21
4 years ago |
|
1222
Galecto
GLTO
$3.42M
|
MA
Martin Auster
| $2.58 | $300 |
11,528%
upside
| Outperform |
16 Mar ‘21
4 years ago |
|
1223
Air Products & Chemicals
APD
$63.9B
|
KDB
Kieran De Brun
| $287.14 | $302 |
5%
upside
| Outperform |
15 Mar ‘21
4 years ago |
|
1224
Ashland
ASH
$2.44B
|
KDB
Kieran De Brun
| $53.32 | $103 |
93%
upside
| Outperform |
15 Mar ‘21
4 years ago |
|
1225
Axalta
AXTA
$6.8B
|
KDB
Kieran De Brun
| $31.41 | $35 |
11%
upside
| Outperform |
15 Mar ‘21
4 years ago |
|